| Grant number: | 06/02183-1 |
| Support Opportunities: | Regular Research Grants |
| Start date: | September 01, 2006 |
| End date: | August 31, 2009 |
| Field of knowledge: | Health Sciences - Medicine - Pathological Anatomy and Clinical Pathology |
| Principal Investigator: | Fernando Augusto Soares |
| Grantee: | Fernando Augusto Soares |
| Host Institution: | Hospital A C Camargo. Fundação Antonio Prudente (FAP). São Paulo , SP, Brazil |
| City of the host institution: | São Paulo |
Abstract
Classical Hodgkin lymphoma is a monoclonal lymphoid neoplasm whose hallmark is the Reed-Sternberg cell and its variants, which are surrounded by an inflamatory background. Although extensively studied, many aspects of its pathogenesis, specially those involving the programmed cell death pathway, are still not understood. The role of Epstein-Barr virus (EBV), which is detected in aproximately 50% of Hodgkin lymphomas, is also not well established. Although data on EBV association with clinical outcome of Hodgkin lymphoma patients are controversial, some studies suggest that the cases in which EBV is detected follow a different pathway leading to apoptosis blockage. This can stimulate the search for new treatments based on the presence or absence of EBV. Studies employing differential gene expression techniques can add new information to help solving these questions. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |